Phase I/II study of adjuvant therapy after liver transplantation in the recipients with advanced hepoatocellular carcinoma
Not Applicable
Recruiting
- Conditions
- iver transplant recipients with advanced hepatocellular carcinoma beyond Milan criteria
- Registration Number
- JPRN-UMIN000005667
- Lead Sponsor
- Osaka University Graduate School of Medicine, Department of Surgery
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
renal dysfunction, ABO incompatible transplant, HIV positive, and others
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method safety, recurrence rate and site of HCC
- Secondary Outcome Measures
Name Time Method graft survival, patient survival, incidence of acute cellular rejection and chronic rejection